湖北科技学院学报（医学版）

[1]ROSENBERG B,CAMP V,GRIMLEY E B,et al.The inhibition of growth or cell division in escherichia coli by different ionic species of platinum(IV) complexes[J].J Biol Chem,1967,242(6):1347

[2]隋晶,刘清华.原发性肝癌的药物治疗进展[J].滨州医学院学报,2018,41(1):56

[3]章必成,朱波.晚期非小细胞肺癌化学治疗的现状与未来[J].医药导报,2018,37(5):531

[4]王淋丽,李娜,陈波,等.非小细胞肺癌一线化疗药物的研究进展[J].中国药房,2016,27(5):717

[5]HOLZER A.K,MANOREK G H,HOWELL S B.Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin,carboplatin,and oxaliplatin[J].Mol Pharmacol,2006,70(4):1390

[6]ARANY I,SAFIRSTEIN R L.Cisplatin nephrotoxicity[J].Semin Nephrol,2003,23(5):460

[7]RICHARD J B,PHILIP J R,MARYAM P.Drug delivery strategies for platinum-based chemotherapy[J].ACS Nano,2017,11(9):8560

[8]LIN X,CHEN X,RIDDELL I A.Glutathione-scavenging poly(disulfide amide)nanoparticles for effective delivery of Pt(IV) prodrugs and reversal of cisplatin resistance[J].Nano Lett,2018,18(7):4618

[9]WANG S S,SCHARADIN T M,ZIMMERMANN M.Correlation of platinum cytotoxicity to drug-DNA adduct levels in a breast cancer cell line panel[J].Chem Res Toxicol,2018,31(12):1293

[10]POON C,DUAN X P,CHAN C.Nanoscale coordination polymers co-deliver carboplatin and gemcitabine for highly effective treatment of platinum-resistant ovarian cancer[J].Mol Pharmaceutics,2016,13(11):3665

[11]许凤杰,刘瑞斯,彪林海,等.抗癌药物奥沙利铂与DNA分子相互作用的研究[J].生物化学与生物物理进展,2016,43(7):684

[12]KELLAND L.The resurgence of platinum-based cancer chemo therapy[J].Nat Rev Cancer,2007,7(8):573

[13]ABU A A,RAVEENDRAN R,GIBSON D.A lipophilic pt(IV) oxaliplatin derivative enhances antitumor activity[J].J Med Chem,2016,59(19):9035

[14]PETER M B,LIU Y P,GA YOUNG PARK.A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress[J].Nat Med,2017,23(4):461

[15]高传柱,蔡林祥,李军,等.基于非经典结构的抗肿瘤铂配合物的研究进展[J].昆明理工大学学报(自然科学版),2018,43(3):70

[16]WANG Z M,YU H Y,GOU S H.Design synthesis and biological features of platinum(Ⅱ) complexes with rigid steric hindrance[J].Inorg Chem,2016,55(9):4519

[17]LIU F F,GOU S H,CHEN F H.Study on antitumor platinum(II) complexes of chiral diamines with dicyclic species as steric hindrance[J].Med Chem,2015,58(16):6368

[18]Phosplatin therapeutics.http://phosplatin.com (July 30,2016).

[19]PLACON THERAPEUTICS.Placon therapeutics announces company launch and FDA acceptance of IND for novel platinum candidate BTP-114.http://www.placontx.com/wp-content/uploads/2016/03/FDA-Acceptance-of-IND-forNovel-Platinum-Candidate-BTP-114_032316

[20]YU J J,YANG X,SONG Q,et al.Dicycloplatin,a novel platinum analog in chemotherapy:synthesis of Chinese pre-clinical and clinical profile and emerging mechanistic studies[J].Anticancer Res,2014,349(1):455

[21]DASARI S,TCHOUNWOU P B.Cisplatin in cancer therapy:molecular mechanisms of action[J].Eur J Pharmacol,2014,740:364

[22]房田田,曹开明,程岚军,等.铂类抗肿瘤药物与蛋白质的作用机理[J].中国科学:化学,2017,47(2):200

[23]张亚娟,常德,李建鹏.肺癌化疗中铂类耐药的研究进展[J].中国医学科学院学报,2017,39(01):150

[24]胡倩倩,王振辉,牛超,等.铂类抗肿瘤药物耐药机制研究进展[J].药物进展,2017,41(10):769

[25]JIN S X,GUO Y,SONG D F.Targeting energy metabolism by a platinum(IV) prodrug as an alternative pathway for cancer suppression[J].Inorg Chem,2019,58 (9):6507

[26]KENNY R G,MARMION C J.Toward multi-targeted platinum and ruthenium drugs a new paradigm in cancer drug treatment regimens[J].Chem Rev,2019,119(2):1058

[27]GRéGORY T,LOUIS H B,YOO J G.Platinum(IV)-ferrocene conjugates and their cyclodextrin host-guest complexes[J].Inorg Chem,2019,58(12):7886

[28]HUANG X C,HUANG R Z,GOU S H.Anticancer platinum(Ⅳ) prodrugs containing monoaminophosphonate ester as a targeting group inhibit matrix metalloproteinases and reverse multidrug resistance[J].Bioconjugate Chem,2017,28(4):1305

[29]MA L L,LIN X D,LI C.A cancer cell-selective and low-toxic bifunctional heterodinuclear pt(Ⅳ)-ru(Ⅱ) anticancer prodrug[J].Inorg Chem,2018,57(5):2917

[30]LI TIANYU,MARIO SMET,WIM DEHAEN.Selenium-platinum coordination dendrimers with controlled anticancer activity[J].ACS Appl Mater,2015,8(6):3609

[31]MALGORZATA FRIK,JACOB FERNANDEZ-GALLARDO,OSCAR GONZALO.Cyclometalated iminophosphorane gold(Ⅲ) and platinum(Ⅱ) complexes.A highly permeable cationic platinum(Ⅱ) compound with promising anticancer properties[J].Med Chem,2015,58(15):5825